Related Experiment Video
Updated: Jul 10, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
The disease with hope: hairy cell leukemia
1Potomac Hospital, Woodbridge, VA, USA. sueccu@yahoo.com
Clinical Journal of Oncology Nursing
|October 27, 2007
Summary
Hairy cell leukemia (HCL) treatments have advanced significantly. Newer therapies like 2-chlorodeoxyadenosine and BL22 offer high remission rates and improved patient prognoses for this rare leukemia.
Area of Science:
- Hematology
- Oncology
Background:
- Hairy cell leukemia (HCL) is a rare chronic leukemia accounting for 2% of all leukemia cases.
- Characterized by mononuclear cells with distinctive cytoplasmic projections.
Observation:
- Traditional treatments included splenectomy and interferon alpha, yielding high response rates but limited complete remission.
- Recent advancements focus on purine analog chemotherapy and targeted immunotherapies.
Findings:
- 2-chlorodeoxyadenosine therapy achieves 85%-90% complete remission with minimal toxicity and low relapse rates.
- Anti-CD22 recombinant immunotoxin BL22 shows promising results in new research.
- A second course of therapy is available for resistant or recurrent HCL.
Implications:
- Current chemotherapy options significantly improve patient prognoses for hairy cell leukemia.
- The development of targeted therapies like BL22 offers new hope for HCL patients.
- Optimistic outlook for managing this chronic lymphoid leukemia.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...